Holen Sie sich die Stockscreener-App
30.17
1.73%
-0.53
Handel nachbörslich:
30.44
0.27
+0.89%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ALKS?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$30.70
Offen:
$30.34
24-Stunden-Volumen:
2.45M
Relative Volume:
1.24
Marktkapitalisierung:
$4.98B
Einnahmen:
$1.51B
Nettoeinkommen (Verlust:
$333.35M
KGV:
15.47
EPS:
1.95
Netto-Cashflow:
$315.22M
1W Leistung:
+1.51%
1M Leistung:
-2.87%
6M Leistung:
-5.07%
1J Leistung:
+13.98%
1-Tages-Spanne:
$29.70
$30.69
1-Wochen-Bereich:
$28.41
$32.13
52-Wochen-Spanne:
$25.16
$36.45
Alkermes Plc Stock (ALKS) Company Profile
Firmenname
Alkermes Plc
Sektor
Telefon
00-353-1-772-8000
Adresse
CONNAUGHT HOUSE, DUBLIN 4
Vergleichen Sie ALKS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALKS
Alkermes Plc
|
30.17 | 5.07B | 1.51B | 333.35M | 315.22M | 1.95 |
|
ZTS
Zoetis Inc
|
144.35 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.42 | 42.46B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.38 | 41.28B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.52 | 23.49B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
438.66 | 19.18B | 3.08B | 1.24B | 1.07B | 25.61 |
Alkermes Plc Stock (ALKS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-26 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-09-03 | Eingeleitet | Wells Fargo | Overweight |
| 2025-07-15 | Eingeleitet | Goldman | Buy |
| 2025-06-17 | Hochstufung | UBS | Neutral → Buy |
| 2025-05-28 | Eingeleitet | Needham | Buy |
| 2025-03-13 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2025-03-04 | Hochstufung | UBS | Sell → Neutral |
| 2025-02-11 | Eingeleitet | Deutsche Bank | Buy |
| 2024-11-05 | Hochstufung | Stifel | Hold → Buy |
| 2024-06-17 | Eingeleitet | TD Cowen | Buy |
| 2024-03-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-02-20 | Herabstufung | UBS | Neutral → Sell |
| 2023-11-20 | Fortgesetzt | JP Morgan | Neutral |
| 2023-10-24 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-10-17 | Eingeleitet | UBS | Neutral |
| 2022-11-03 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-10-14 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-08-16 | Eingeleitet | Piper Sandler | Neutral |
| 2022-04-22 | Fortgesetzt | Goldman | Buy |
| 2022-04-20 | Eingeleitet | Goldman | Buy |
| 2022-01-27 | Hochstufung | Cantor Fitzgerald | Hold → Overweight |
| 2021-12-01 | Eingeleitet | Citigroup | Neutral |
| 2021-10-07 | Hochstufung | Jefferies | Hold → Buy |
| 2021-09-02 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2020-10-15 | Hochstufung | Mizuho | Neutral → Buy |
| 2020-07-30 | Herabstufung | Goldman | Neutral → Sell |
| 2020-02-14 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2020-02-14 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-02-14 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-02-06 | Eingeleitet | Mizuho | Neutral |
| 2020-01-31 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2019-09-05 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2019-07-15 | Hochstufung | Goldman | Sell → Neutral |
| 2019-05-31 | Eingeleitet | H.C. Wainwright | Neutral |
| 2019-05-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2018-12-19 | Herabstufung | Goldman | Neutral → Sell |
| 2018-12-14 | Eingeleitet | Wolfe Research | Underperform |
| 2018-12-13 | Herabstufung | Credit Suisse | Outperform → Underperform |
| 2018-11-05 | Eingeleitet | Piper Jaffray | Neutral |
| 2018-08-07 | Eingeleitet | Stifel | Hold |
| 2018-06-21 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2018-06-06 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2018-05-16 | Hochstufung | Citigroup | Neutral → Buy |
| 2018-05-11 | Eingeleitet | BofA/Merrill | Buy |
Alle ansehen
Alkermes Plc Aktie (ALKS) Neueste Nachrichten
Can Alkermes plc stock maintain growth trajectoryJuly 2025 Institutional & Safe Capital Investment Plans - newser.com
Applying Elliott Wave Theory to Alkermes plcDay Trade & Breakout Confirmation Trade Signals - newser.com
How Alkermes plc (8AK) stock valuation compares with sector2025 Sector Review & Low Risk High Win Rate Picks - newser.com
Why Alkermes plc stock is seen as undervaluedQuarterly Portfolio Review & High Conviction Trade Alerts - newser.com
What moving averages say about Alkermes plcQuarterly Portfolio Summary & Daily Oversold Stock Bounce Ideas - newser.com
Risk vs reward if holding onto Alkermes plcGDP Growth & Technical Entry and Exit Alerts - newser.com
Is Alkermes plc (8AK) stock at risk of policy regulationGold Moves & Weekly Chart Analysis and Guides - newser.com
Relative strength of Alkermes plc in sector analysisJuly 2025 Drop Watch & AI Powered Market Entry Strategies - newser.com
How resilient is Alkermes plc stock in market downturnsOptions Play & Expert-Curated Trade Recommendations - newser.com
Is Alkermes plc forming a bottoming base2025 Technical Overview & Stock Timing and Entry Methods - newser.com
Is Alkermes plc (8AK) stock a safe buy pre earningsCEO Change & Weekly Watchlist for Hot Stocks - newser.com
Price momentum metrics for Alkermes plc explainedTrade Risk Summary & Technical Buy Zone Confirmations - newser.com
What to do if you’re stuck in Alkermes plc2025 Historical Comparison & Weekly Setup with High ROI Potential - newser.com
Why Alkermes plc stock appeals to analysts2025 Breakouts & Breakdowns & Daily Profit Maximizing Trade Tips - newser.com
What recovery options are there for Alkermes plc2025 Price Momentum & Daily Market Momentum Tracking - newser.com
Applying Wyckoff theory to Alkermes plc stockMarket Sentiment Review & Safe Swing Trade Setup Alerts - newser.com
Exit strategy if you’re trapped in Alkermes plcJuly 2025 Closing Moves & Safe Swing Trade Setup Alerts - newser.com
Jennison Associates LLC Buys New Position in Alkermes plc $ALKS - MarketBeat
State of New Jersey Common Pension Fund D Boosts Stock Holdings in Alkermes plc $ALKS - MarketBeat
Alkermes plc (NASDAQ:ALKS) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Alkermes (NASDAQ:ALKS) Rating Increased to Strong-Buy at Wall Street Zen - MarketBeat
Moody Aldrich Partners LLC Has $1.92 Million Stock Position in Alkermes plc $ALKS - MarketBeat
Order flow analysis tools used on Alkermes plcMarket Risk Analysis & Stock Portfolio Risk Management - newser.com
Alkermes plc Just Recorded A 62% EPS Beat: Here's What Analysts Are Forecasting Next - simplywall.st
Can Alkermes plc stock deliver consistent earnings growthMarket Sentiment Report & Free Growth Oriented Trading Recommendations - newser.com
Real time social sentiment graph for Alkermes plcBuy Signal & Free Accurate Trade Setup Notifications - newser.com
Published on: 2025-10-31 00:36:26 - newser.com
Finanzdaten der Alkermes Plc-Aktie (ALKS)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.35%
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):